MedTrace Logo

Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women

NCT01839643 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2019-04-30

No results posted yet for this study

Summary

In this study, the investigators propose to assess if a non-hormonal agent is absorbed by a local route (vaginal) and to observe the effect on follicular development.

Conditions

  • Contraception
  • Bleeding Pattern

Interventions

DRUG

Meloxicam 2.4 g

2.4 g in Vaginal Ring

DRUG

Meloxicam 3.0 g

3.0 g in Vaginal Ring

Sponsors & Collaborators

  • Instituto Chileno de Medicina Reproductiva

    collaborator OTHER

  • Laboratorios Andromaco S.A.

    lead INDUSTRY

Principal Investigators

  • Grünenthal Study Director · Grünenthal GmbH

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-15
Primary Completion
2013-05-07
Completion
2013-06-06

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01839643 on ClinicalTrials.gov